Interpore downgrades sales, slams "invalid patent" ruling
This article was originally published in Clinica
Spinal implants producer Interpore Cross International was last week reeling from a double volley of bad news. In late March, the company was told by the Central District of California court that a patent held by subsidiary Cross Medical Products (CMP) was invalid, weakening its position in its ongoing patent lawsuit against DePuy Acromed. This suit claimed that DePuy's MOSS-Miami line infringed two CMP patents.